Evidence map›Paper›PMID 35050001›Full record

ArticleJournal of fungi (Basel, Switzerland)2022

Characterization of the

Pedro Pais, Mónica Galocha, Raquel Califórnia, Romeu Viana, Mihaela Ola, Michiyo Okamoto, Hiroji Chibana, Geraldine Butler, Miguel C Teixeira

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. mSphere · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Pedro PaisDepartment of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.ORCID 0000-0001-5628-416X
Mónica GalochaDepartment of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.
Raquel CalifórniaDepartment of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.ORCID 0000-0002-5090-9621
Romeu VianaDepartment of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.
Mihaela OlaSchool of Biomedical and Biomolecular Sciences, Conway Institute, University College Dublin, Dublin 4, Ireland.
Michiyo OkamotoMedical Mycology Research Center (MMRC), Chiba University, Chiba 263-8522, Japan.
Hiroji ChibanaMedical Mycology Research Center (MMRC), Chiba University, Chiba 263-8522, Japan.
Geraldine ButlerSchool of Biomedical and Biomolecular Sciences, Conway Institute, University College Dublin, Dublin 4, Ireland.ORCID 0000-0002-1770-5301
Miguel C TeixeiraDepartment of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.ORCID 0000-0002-5676-6174
University of Lisbon · PTChiba University Hospital · JPUniversity College Dublin · IE

Funding

Fundação para a Ciência e Tecnologia LA/P/0140/2020Fundação para a Ciência e Tecnologia PTDC/BII-BIO/28216/2017Fundação para a Ciência e Tecnologia UIDB/04469/2020Fundação para a Ciência e Tecnologia UIDB/04565/2020Fundação para a Ciência e Tecnologia UIDP/04565/2020
6 · The paper itself

Abstract

The prevalence of antifungal resistance in

Indexed as

azole resistanceCandida glabrataCgMar1CgRsb1transcription regulatory networkstranscriptomics

Identifiers

PMID35050001
PMCPMC8779156
OpenAlexW4206824905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.